DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Advair HFA (Fluticasone Propionate / Salmeterol Xinafoate) - Published Studies

 
 



Advair HFA Related Published Studies

Well-designed clinical trials related to Advair HFA (Fluticasone / Salmeterol)

Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers. [2011.04]

Comparison of heat-sensitive moxibustion versus fluticasone/salmeterol (seretide) combination in the treatment of chronic persistent asthma: design of a multicenter randomized controlled trial. [2010.12.15]

A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination. [2009.08]

Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. [2009.04]

The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. [2008.06.01]

Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]

Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. [2007.04]

Lower inhaled steroid requirement with a fluticasone/salmeterol combination in family practice patients with asthma or COPD. [2007.04]

Can inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT00120978]. [2006.02.06]

Effect of fluticasone/salmeterol administered via a single device on exercise-induced bronchospasm in patients with persistent asthma. [2005.01]

[Efficacy and acceptability of the fixed fluticasone + salmeterol combination in the treatment of acute asthma attacks. Results of a one-year comparative study] [2004.09]

[A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination] [2003.11]

Effects of fluticasone vs. fluticasone/salmeterol on airway calibre and airway hyperresponsiveness in mild persistent asthma. [2003.07]

Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone. [2002.06]

Well-designed clinical trials possibly related to Advair HFA (Fluticasone / Salmeterol)

Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD. [2008.11]

Budesomide/ formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation. [2008.06]

Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. [2007.10]

Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. [2007.08]

Airway blood flow reactivity in healthy smokers and in ex-smokers with or without COPD. [2006.04]

Adding salmeterol to an inhaled corticosteroid reduces allergen-induced serum IL-5 and peripheral blood eosinophils. [2005.11]

The Canadian Optimal Therapy of COPD Trial: design, organization and patient recruitment. [2004.11]

Effects of montelukast on surrogate inflammatory markers in corticosteroid-treated patients with asthma. [2003.05.01]

Other research related to Advair HFA (Fluticasone / Salmeterol)

Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD. [2012.01]

Comparison of budesonide/formoterol Turbuhaler with fluticasone/salmeterol Diskus for treatment effects on small airway impairment and airway inflammation in patients with asthma. [2011.10]

FLUTICASONE/SALMETEROL COMBINATION CONFERS BENEFITS IN SMOKING ASTHMATICS. [2011.06.02]

Fluticasone/formoterol combination therapy is as effective as fluticasone/salmeterol in the treatment of asthma, but has a more rapid onset of action: an open-label, randomized study. [2011.05.23]

Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers. [2011]

Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study. [2011]

Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. [2011]

Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer. [2010.06]

Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer. [2010]

Comparison of heat-sensitive moxibustion versus fluticasone/salmeterol (seretide) combination in the treatment of chronic persistent asthma: design of a multicenter randomized controlled trial. [2010]

Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. [2009.12]

Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population. [2009.03]

Acute care among asthma patients using budesonide/formoterol or fluticasone propionate/salmeterol. [2009.02]

Healthcare use and costs in patients with chronic bronchitis initiating maintenance therapy with fluticasone/salmeterol vs other inhaled maintenance therapies. [2009.01]

Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. [2008.07.16]

The Effects of Fluticasone With or Without Salmeterol On Systemic Biomarkers of Inflammation in COPD. [2008.03.06]

Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. [2007.10]

Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone. [2007.06]

Cushing syndrome and severe adrenal suppression caused by fluticasone and protease inhibitor combination in an HIV-infected adolescent. [2007.06]

Fluticasone propionate/salmeterol hydrofluoroalkane via metered-dose inhaler with integrated dose counter: Performance and patient satisfaction. [2006.10]

Maintenance asthma treatment with fluticasone/salmeterol combination via Diskus: effect on outcomes in inner-city children enrolled in TennCare. [2005.03]

Effects of low dose fluticasone/salmeterol combination on surrogate inflammatory markers in moderate persistent asthma. [2003.07]

Other possibly related research studies

Performance of large- and small-volume valved holding chambers with a new combination long-term bronchodilator/anti-inflammatory formulation delivered by pressurized metered dose inhaler. [2002.01]

Pharmacological strategies for self-management of asthma exacerbations. [2006.07]

Patient-centred outcomes in primary care management of COPD - what do recent clinical trial data tell us? [2004.12]

Adherence to asthma controller medication regimens. [2005.10]

New treatment options in COPD. [2005.07]

Improving asthma control in patients suboptimally controlled on inhaled steroids and long-acting beta2-agonists: addition of montelukast in an open-label pilot study. [2005.06]

Changes in prescribing of inhaled corticosteroids (1999-2002) in Scotland. [2005.03]

Combined corticosteroid and long acting beta-agonist in one inhaler for chronic obstructive pulmonary disease. [2004]

Combined corticosteroid and longacting beta-agonist in one inhaler for chronic obstructive pulmonary disease. [2003]

Inhaled steroids in asthma. Should the doses be reduced? [2002.08]

A modified prescription-event monitoring study to assess the introduction of Seretide Evohaler in England: an example of studying risk monitoring in pharmacovigilance. [2007]

Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease. [2007.10.17]

Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease. [2007.10.17]

Fixed combination therapies in COPD--effect on quality of life. [2007]

A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease. [2008.08]

Cost-Effectiveness of Therapy with Combinations of Long-Acting Bronchodilators and Inhaled Steroids for Treatment of COPD. [2008.07.11]

Inhalational diesel exhaust exposure in submariners: observational study. [2008.07]

Economic assessment of initial maintenance therapy for chronic obstructive pulmonary disease. [2008.07]

Adolescents and asthma: why bother with our meds? [2009.06]

Efficacy of add-on montelukast in patients with non-controlled asthma: a Belgian open-label study. [2009.02]

Effectiveness of combination therapies in asthma: an observational study. [2009.06]

Seretide: a pharmacoeconomic analysis. [2008]

Symbicort: a pharmacoeconomic review. [2008]

Iatrogenic Cushing's syndrome due to coadministration of ritonavir and inhaled budesonide in an asthmatic human immunodeficiency virus infected patient. [2010.09]

Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler. [2010.05]

Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease. [2010.05.12]

Poor disease control among insured users of high-dose combination therapy for asthma. [2010.01]

Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. [2010.06]

Efficacy of a fixed combination of ciclesonide and formoterol: The EXCITED-study. [2012.01]

Azathioprine-induced fever in sarcoidosis. [2011.03]

Adherence to controller therapy for chronic obstructive pulmonary disease: a review. [2010.10]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014